Cowen And Company, LLC Sarepta Therapeutics, Inc. Call Options Transaction History

Cowen And Company, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 07, 2024	BUY	$113.33 - $163.85 $1.99 Million - $2.88 Million	17,600 New	17,600 $2.78 Million
Q2 2022 Aug 05, 2022	SELL	$62.69 - $88.44 $752,280 - $1.06 Million	-12,000 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$63.15 - $90.42 $1.26 Million - $1.81 Million	-20,000 Reduced 62.5%	12,000 $30,000
Q4 2021 Feb 14, 2022	BUY	$77.28 - $99.42 $2.36 Million - $3.03 Million	30,500 Added 2033.33%	32,000 $161,000
Q3 2021 Nov 12, 2021	BUY	$65.97 - $92.48 $98,955 - $138,720	1,500 New	1,500 $18,000

528

84M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.2B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.